scispace - formally typeset
H

Ho Sup Yoon

Researcher at Nanyang Technological University

Publications -  135
Citations -  9331

Ho Sup Yoon is an academic researcher from Nanyang Technological University. The author has contributed to research in topics: FKBP & Protein structure. The author has an hindex of 34, co-authored 134 publications receiving 8718 citations. Previous affiliations of Ho Sup Yoon include Kyung Hee University & University of Chicago.

Papers
More filters
Journal ArticleDOI

Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis.

TL;DR: The structure and binding affinities of mutant Bak peptides indicate that the Bak peptide adopts an amphipathic α helix that interacts with Bcl-xL through hydrophobic and electrostatic interactions.
Journal ArticleDOI

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.

TL;DR: The arrangement of the α-helices in Bcl-xL is reminiscent of the membrane translocation domain of bacterial toxins, in particular diphia toxin and the colicins, and may provide a clue to the mechanism of action of the B cl-2 family of proteins.
Journal ArticleDOI

Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate.

TL;DR: It is reported that pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate and shown that the lipid-binding site is located at the lip of the β-barrel.
Journal ArticleDOI

Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer.

TL;DR: Cationic core–shell nanoparticles that were self-assembled from a biodegradable amphiphilic copolymer offer advantages over liposomes, as they are easier to fabricate, and are more readily subject to modulation of their size and degree of positive charge.
Journal ArticleDOI

Correction: Corrigendum: Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells

TL;DR: In this paper, the authors found that ursolic acid (UA) inhibits the catalytic activity of vaccine-related kinase 1 via direct binding to the protein domain of VRK1.